Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
Open Access
- 12 February 2021
- Vol. 11 (2), e043584
- https://doi.org/10.1136/bmjopen-2020-043584
Abstract
Objective We sought to determine the extent of SARS-CoV-2 seroprevalence and the factors associated with seroprevalence across a diverse cohort of healthcare workers. Design Observational cohort study of healthcare workers, including SARS-CoV-2 serology testing and participant questionnaires. Settings A multisite healthcare delivery system located in Los Angeles County. Participants A diverse and unselected population of adults (n=6062) employed in a multisite healthcare delivery system located in Los Angeles County, including individuals with direct patient contact and others with non-patient-oriented work functions. Main outcomes Using Bayesian and multivariate analyses, we estimated seroprevalence and factors associated with seropositivity and antibody levels, including pre-existing demographic and clinical characteristics; potential COVID-19 illness-related exposures; and symptoms consistent with COVID-19 infection. Results We observed a seroprevalence rate of 4.1%, with anosmia as the most prominently associated self-reported symptom (OR 11.04, pConclusion and relevance The demographic factors associated with SARS-CoV-2 seroprevalence among our healthcare workers underscore the importance of exposure sources beyond the workplace. The size and diversity of our study population, combined with robust survey and modelling techniques, provide a vibrant picture of the demographic factors, exposures and symptoms that can identify individuals with susceptibility as well as potential to mount an immune response to COVID-19.Keywords
Funding Information
- Cedars-Sinai Medical Center
- Erika J. Glazer Family Foundation
- National Cancer Institute (U54-CA260591)
- National Heart, Lung, and Blood Institute (K23-HL153888)
This publication has 36 references indexed in Scilit:
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and IncomeAmerican Journal of Preventive Medicine, 2020
- Will antibody tests for the coronavirus really change everything?Nature, 2020
- Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European studyEuropean Archives of Oto-Rhino-Laryngology, 2020
- Developing antibody tests for SARS-CoV-2The Lancet, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- mipfp: An R Package for Multidimensional Array Fitting and Simulating Multivariate Bernoulli DistributionsJournal of Statistical Software, 2018
- Stan: A Probabilistic Programming LanguageJournal of Statistical Software, 2017
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older AdultsThe New England Journal of Medicine, 2014
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008